Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

TSX/ABBV stock hub

TSX/ABBV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/ABBVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

487.5B

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/ABBV

In the news

Latest news · TSX/ABBV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 n/aP50 n/aP75 n/a

Trailing P/E97.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC22.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/ABBV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CA
Employees	57,000
Employees Change	5,000%
Employees Change Percent	10
Enterprise value	CAD 574.5B
Exchange	Toronto Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	CAD 487.5B
Price	CAD 28.23
Price currency	CAD
Rev Per Employee	1,538,360.16x
Sic	2836
Symbol	tsx/ABBV
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.03%
EV Earnings	114.48x
EV/EBIT	19.18x
EV/EBITDA	13.85x
EV/FCF	20.6x
EV/Sales	6.68x
FCF yield	5.72%
Forward P/E	13.5x
P/B ratio	-52.82x
P/E ratio	97.14x
P/S ratio	5.56x
PE Ratio10 Y	39.99x
PE Ratio3 Y	77.83x
PE Ratio5 Y	56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.83%
EBITDA Margin	47.62%
FCF margin	31.81%
Gross margin	72.03%
Gross Profit	CAD 63.2B
Gross Profit Growth	11.06%
Gross Profit Growth Q	15.45%
Gross Profit Growth3 Y	3.97%
Gross Profit Growth5 Y	5.95%
Net Income	CAD 5B
Net Income Growth	-13.35%
Net Income Growth Q	-45.96%
Net Income Growth3 Y	-21.86%
Net Income Growth5 Y	-6.73%
Pretax Margin	9.51%
Profit Margin	5.79%
Profit Per Employee	CAD 88,037
ROA	10.03
Roa5y	8.68
ROCE	23.19
Roe5y	1,295.2
ROIC	22.24
Roic5y	22.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.1%
Cagr3y	11.78%
EPS Growth	-13.24
EPS Growth Q	-45.83
EPS Growth3 Y	-21.78
EPS Growth5 Y	-6.98
Revenue Growth	9.5x
Revenue Growth Q	12.43x
Revenue Growth3 Y	3.45x
Revenue Growth5 Y	4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.46
Assets	CAD 190.5B
Cash	CAD 13.1B
Debt	CAD 101.8B
Debt EBITDA	CAD 2.41
Debt FCF	CAD 3.65
Equity	CAD -9.2B
Interest Coverage	7.52
Liabilities	CAD 199.7B
Net Cash	CAD -88.7B
Net Cash By Market Cap	CAD -18.19
Net Debt EBITDA	CAD 2.12
Net Debt FCF	CAD 3.18
Tangible Book Value	CAD -130B
Tangible Book Value Per Share	CAD -73.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	3.67
Net Working Capital	CAD -13.4B
Quick ratio	0.52
Working Capital	CAD -12B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	28.68%
Dividend Growth Years	2%
Dividend per share	CAD 1.19
Dividend Years	3
Dividend Yield	4.21%
Ex Div Date	2026-04-15
Last Dividend	CAD 0.24
Payout Frequency	Quarterly
Payout Ratio	325.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.09%
200-day SMA	30.75
3Y total return	39.68%
50-day SMA	29.8
50-day SMA vs 200-day SMA	50under200
All Time High	34.48
All Time High Change	-18.13%
All Time High Date	2025-10-02
All Time Low	19.45
All Time Low Change	45.14%
All Time Low Date	2023-06-28
ATR	0.59
Ch YTD	-12.87
High	28.23
High52	34.48
High52 Date	2025-10-02
High52ch	-18.13%
Low	28.08
Low52	25.35
Low52 Date	2025-05-15
Low52ch	11.36%
Ma50ch	-5.26%
Price vs 200-day SMA	-8.21%
RSI	42.57
RSI Monthly	49.11
RSI Weekly	40.54
Sharpe ratio	0.2x
Sortino ratio	0.5
Total Return	4.17%
Tr YTD	-10.74
Tr1m	-1.71%
Tr1w	-2.42%
Tr3m	-10.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 30.5B
Operating Income Growth	15
Operating Income Growth Q	16.6
Operating Income Growth3 Y	0.7
Operating Income Growth5 Y	5.78
Operating margin	34.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,680,450%
Shares Insiders	0.07%
Shares Institutions	76.02%
Shares Qo Q	0%
Shares Yo Y	0.04%
Short Ratio	3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 26.5B
Average Volume	11,210.9x
Bv Per Share	-5.26
CAPEX	CAD -1.7B
Ch1m	-2.52
Ch1w	-2.42
Ch1y	4.83
Ch3m	-10.89
Ch3y	28.32
Ch6m	-9.11
Change	-0.28%
Change From Open	0.5
Close	28.31
Days Gap	-0.78
Depreciation Amortization	11,120,609,987.5
Dollar Volume	57,250.4
Earnings Date	2026-04-29
EBIT	CAD 30.5B
EBITDA	CAD 41.8B
EPS	CAD 2.83
F Score	7
FCF	CAD 27.9B
FCF EV Yield	4.85x
Financing CF	-14,722,135,420
Fiscal Year End	December
Founded	2,012
Income Tax	CAD 3.3B
Investing CF	-9,047,964,520
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	CAD 1.45
Lynch Upside	-94.85
Ma150	31.19
Ma150ch	-9.5%
Ma20	28.69
Ma20ch	-1.61%
Net CF	5,884,945,760
Open	28.09
P FCF Ratio	17.48
P OCF Ratio	16.45
Payment Date	2026-05-25
Position In Range	100
Price Date	2026-05-08
Price EBITDA	CAD 11.67
Relative Volume	0.18x
Revenue	87,686,529,340x
SBC By Revenue	1.57x
Share Based Comp	1,380,505,540
Tax By Revenue	3.72x
Tax Rate	39.06%
Tr6m	-6.89%
Volume	2,028
Z Score	2.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TSX/ABBV dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.2%

$1.19 annual per share

Payout ratio

+325.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+4.2%

Next ex-dividend date: 2026-04-15

Performance

TSX/ABBV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/ABBV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TSX/ABBV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.6

Neutral momentum band

Price vs 200-day MA

-8.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/ABBV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/ABBV stock rating?

tsx/ABBV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/ABBV analysis?

The full report lives at /stocks/tsx/ABBV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/ABBV?

The latest report frames tsx/ABBV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/ABBV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.